Relmada Therapeutics RLMD
NASDAQ RLMD
$3.73 -0.06 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019)

Updated

Relmada Therapeutics' (RLMD) Debt Ratio came in at 0.00 for FY2019.

Analysis

Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019) Analysis & Trends

Since FY2014, Relmada Therapeutics has reported Debt Ratio for 6 years.

  • The FY2019 figure stands as the lowest annual Debt Ratio in data going back to FY2014.
  • Business Quant data shows RLMD's Debt Ratio at 0.97 in FY2018 (+889.6%), 0.10 in FY2017 (+265.1%), 0.03 in FY2016 (+147.1%) and 0.01 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Relmada Therapeutics 404.28 Mn 404.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 0.00
Sep 30, 2019 0.03
Jun 30, 2019 0.04
Mar 31, 2019 0.01
Dec 31, 2018 0.03
Sep 30, 2018 2.18
Jun 30, 2018 0.97
Mar 31, 2018 0.33
Dec 31, 2017 0.21
Sep 30, 2017 0.16
Jun 30, 2017 0.10
Mar 31, 2017 0.01
Dec 31, 2016 0.02
Sep 30, 2016 0.02
Jun 30, 2016 0.03
Dec 31, 2015 0.01
Sep 30, 2015 0.01
Jun 30, 2015 0.01
Dec 31, 2014 0.00
Sep 30, 2014 0.01
API Access

Relmada Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RLMD&period=max&api_key=YOUR_API_KEY